CN106754650B - 一种骨髓来源的内皮祖细胞培养方法 - Google Patents
一种骨髓来源的内皮祖细胞培养方法 Download PDFInfo
- Publication number
- CN106754650B CN106754650B CN201710101892.8A CN201710101892A CN106754650B CN 106754650 B CN106754650 B CN 106754650B CN 201710101892 A CN201710101892 A CN 201710101892A CN 106754650 B CN106754650 B CN 106754650B
- Authority
- CN
- China
- Prior art keywords
- culture
- bone marrow
- cell
- progenitor cells
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 49
- 230000003511 endothelial effect Effects 0.000 title claims abstract description 45
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 45
- 210000001185 bone marrow Anatomy 0.000 title claims abstract description 44
- 210000004027 cell Anatomy 0.000 claims abstract description 52
- 210000005087 mononuclear cell Anatomy 0.000 claims abstract description 27
- 239000002609 medium Substances 0.000 claims abstract description 25
- 230000029087 digestion Effects 0.000 claims abstract description 24
- 239000007788 liquid Substances 0.000 claims abstract description 24
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 21
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims abstract description 18
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims abstract description 18
- 238000000926 separation method Methods 0.000 claims abstract description 16
- 108010071942 Colony-Stimulating Factors Proteins 0.000 claims abstract description 11
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims abstract description 11
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims abstract description 11
- 102000004142 Trypsin Human genes 0.000 claims abstract description 10
- 108090000631 Trypsin Proteins 0.000 claims abstract description 10
- 239000012588 trypsin Substances 0.000 claims abstract description 10
- 239000003102 growth factor Substances 0.000 claims abstract description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims abstract description 8
- 102100037362 Fibronectin Human genes 0.000 claims abstract description 8
- 108010067306 Fibronectins Proteins 0.000 claims abstract description 8
- 238000004115 adherent culture Methods 0.000 claims abstract description 8
- 239000012894 fetal calf serum Substances 0.000 claims abstract description 8
- 238000004140 cleaning Methods 0.000 claims abstract description 7
- 239000003862 glucocorticoid Substances 0.000 claims abstract description 7
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims abstract description 6
- 239000012679 serum free medium Substances 0.000 claims abstract description 6
- 230000008470 skin growth Effects 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims description 12
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims description 9
- 238000011534 incubation Methods 0.000 claims description 7
- 210000001772 blood platelet Anatomy 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 229940037128 systemic glucocorticoids Drugs 0.000 claims description 5
- 238000002255 vaccination Methods 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 5
- 108010019160 Pancreatin Proteins 0.000 claims description 4
- 239000007853 buffer solution Substances 0.000 claims description 4
- 230000002262 irrigation Effects 0.000 claims description 4
- 238000003973 irrigation Methods 0.000 claims description 4
- 229940055695 pancreatin Drugs 0.000 claims description 4
- 239000008055 phosphate buffer solution Substances 0.000 claims description 4
- 210000000689 upper leg Anatomy 0.000 claims description 4
- 206010002091 Anaesthesia Diseases 0.000 claims description 3
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 3
- 230000037005 anaesthesia Effects 0.000 claims description 3
- 208000026106 cerebrovascular disease Diseases 0.000 claims description 3
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 208000030613 peripheral artery disease Diseases 0.000 claims description 3
- 238000012549 training Methods 0.000 claims description 3
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 claims description 2
- 208000027418 Wounds and injury Diseases 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 239000002054 inoculum Substances 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 claims 1
- 230000012010 growth Effects 0.000 claims 1
- 230000035876 healing Effects 0.000 claims 1
- 210000000496 pancreas Anatomy 0.000 claims 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 16
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 abstract description 6
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 abstract description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 abstract description 2
- 229930003268 Vitamin C Natural products 0.000 abstract description 2
- 238000004113 cell culture Methods 0.000 abstract description 2
- 238000011017 operating method Methods 0.000 abstract description 2
- 235000019154 vitamin C Nutrition 0.000 abstract description 2
- 239000011718 vitamin C Substances 0.000 abstract description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 12
- 239000001963 growth medium Substances 0.000 description 10
- 235000010323 ascorbic acid Nutrition 0.000 description 6
- 239000011668 ascorbic acid Substances 0.000 description 6
- 229960005070 ascorbic acid Drugs 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229960000890 hydrocortisone Drugs 0.000 description 6
- 210000004698 lymphocyte Anatomy 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000003321 amplification Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000009762 endothelial cell differentiation Effects 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
- 108010041308 Endothelial Growth Factors Proteins 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 201000002818 limb ischemia Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 231100000033 toxigenic Toxicity 0.000 description 1
- 230000001551 toxigenic effect Effects 0.000 description 1
- 230000005747 tumor angiogenesis Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
- C12N5/0692—Stem cells; Progenitor cells; Precursor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710101892.8A CN106754650B (zh) | 2017-02-24 | 2017-02-24 | 一种骨髓来源的内皮祖细胞培养方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710101892.8A CN106754650B (zh) | 2017-02-24 | 2017-02-24 | 一种骨髓来源的内皮祖细胞培养方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106754650A CN106754650A (zh) | 2017-05-31 |
CN106754650B true CN106754650B (zh) | 2018-10-02 |
Family
ID=58959355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710101892.8A Active CN106754650B (zh) | 2017-02-24 | 2017-02-24 | 一种骨髓来源的内皮祖细胞培养方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106754650B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107674858B (zh) * | 2017-11-17 | 2021-02-05 | 广州赛莱拉干细胞科技股份有限公司 | 骨髓内皮祖细胞的分离培养基和分离方法 |
CN108424879B (zh) * | 2018-01-10 | 2019-04-02 | 暨赛再生医学科技有限公司 | 用于快速繁殖过表达vegf的血管内皮祖细胞的组合物 |
CN108060116B (zh) * | 2018-02-12 | 2020-03-10 | 重庆医科大学附属儿童医院 | 一种胎鼠内皮祖细胞的提取分离培养方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005043121A2 (en) * | 2003-10-31 | 2005-05-12 | Vitatex, Inc. | Blood test prototypes and methods for the detection of circulating tumor and endothelial cells |
DE102004004509B4 (de) * | 2004-01-23 | 2010-07-01 | Epoplus Gmbh Co.Kg | Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden |
CN102872478B (zh) * | 2012-10-19 | 2014-11-26 | 陕西正凡科技发展有限公司 | 一种全生物化组织工程血管的构建方法 |
CN105331575B (zh) * | 2014-08-13 | 2019-01-18 | 苏州方舟基因药业有限公司 | 一种人血管内皮祖细胞的高效扩增培养体系 |
CN106039413B (zh) * | 2015-04-07 | 2021-04-06 | 四川蓝光英诺生物科技股份有限公司 | 制备包含内皮细胞的生物砖的方法以及由此制备的生物砖 |
-
2017
- 2017-02-24 CN CN201710101892.8A patent/CN106754650B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN106754650A (zh) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105969720B (zh) | 一种人类血管内皮细胞培养液及其培养方法 | |
CN110564682B (zh) | 一种大规模生产人脂肪间充质干细胞外泌体的方法 | |
CN106754650B (zh) | 一种骨髓来源的内皮祖细胞培养方法 | |
US20190264179A1 (en) | Serum-free medium inducing differentiation of umbilical cord mesenchymal stem cell into insulin-secretion-like cell and preparation method and use thereof | |
CN106754668A (zh) | 一种干细胞培养液及注射液 | |
CN104450611A (zh) | 一种人羊膜间充质干细胞原代分离及培养方法 | |
CN106038598A (zh) | 人源干细胞分泌生物活性因子与裂解液的制备方法 | |
CN108004207A (zh) | 从脂肪中获取大量脂肪间充质干细胞的方法 | |
CN106801038A (zh) | 一种利用三维细胞培养系统促进脐带血造血干细胞快速稳定增殖的细胞培养方法 | |
CN105154407A (zh) | 一种皮肤修复功能提高的人脂肪干细胞的制备方法及其应用 | |
CN103860597A (zh) | 一种治疗缺血性心肌病的干细胞制剂及其制备方法 | |
CN114874982B (zh) | 一种增强脐带间充质干细胞分泌血管内皮生长因子的培养方法 | |
CN107267453A (zh) | 一种用于培养脂肪间充质干细胞的培养基及其应用 | |
CN106566803A (zh) | 一种培养液及其应用和培养脐带间充质干细胞的方法 | |
CN107287156A (zh) | 一种脂肪间充质干细胞的分离培养方法及其应用 | |
CN113559273B (zh) | 一种静脉注射用成体干细胞的预处理方法、成体干细胞注射液及应用 | |
CN109897815B (zh) | 一种无需包被的脂肪内皮祖细胞的高效分离和培养方法 | |
CN107083359A (zh) | 干细胞培养基及干细胞分离方法 | |
CN105462913A (zh) | 一种诱导人脐带间充质干细胞分化为胰岛β细胞的方法 | |
CN107674858B (zh) | 骨髓内皮祖细胞的分离培养基和分离方法 | |
CN107513519B (zh) | 一种雪旺细胞的培养方法 | |
CN112481206A (zh) | 一种诱导脂肪间充质干细胞因子分泌的培养基及培养方法 | |
CN106606512B (zh) | 一种用于治疗心肌梗死的混合细胞制剂及制备方法与应用 | |
CN104830762A (zh) | 脂肪原始间充质干细胞的增殖培养方法 | |
CN107119020A (zh) | 一种基于miR‑9的肝损伤靶向间充质干细胞及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Culture method of bone marrow derived endothelial progenitor cells Effective date of registration: 20191209 Granted publication date: 20181002 Pledgee: Heilongjiang Xin Xin Investment Guarantee Group Co.,Ltd. Pledgor: HARBIN CAS SCIENCE BIOTECHNOLOGY CO.,LTD. Registration number: Y2019230000009 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201222 Granted publication date: 20181002 Pledgee: Heilongjiang Xin Xin Investment Guarantee Group Co.,Ltd. Pledgor: HARBIN CAS SCIENCE BIOTECHNOLOGY Co.,Ltd. Registration number: Y2019230000009 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A culture method of endothelial progenitor cells derived from bone marrow Effective date of registration: 20210726 Granted publication date: 20181002 Pledgee: Heilongjiang Xinzheng financing guarantee Group Co.,Ltd. Pledgor: HARBIN CAS SCIENCE BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021230000024 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220808 Granted publication date: 20181002 Pledgee: Heilongjiang Xinzheng financing guarantee Group Co.,Ltd. Pledgor: HARBIN CAS SCIENCE BIOTECHNOLOGY CO.,LTD. Registration number: Y2021230000024 |